Improved safety for integrated granulation and drying suites
Extensive safety testing confirms pressure enhancement effects
and identifies safe design limits for integrated systems GEA Pharma Systems in
conjunction with the FSA, the safety specialist centre in Germany, have carried
out an extensive test programme involving over 100 test explosions. This
research has shown conclusively that should an explosion occur during the
transfer operation in an integrated system where a granulator is connected
directly to a fluid bed dryer without an explosion isolation valve, the
secondary explosion pressures in the granulator can be significantly higher
than in the fluid bed. These tests have enabled GEA Pharma Systems to gain
full EC type approval for a range of pressure shock resistant integrated
systems and 16-bar pressure shock resistant high shear granulators.
This extensive research program has significantly advanced the
state-of-the-art in safety technology for pharmaceutical plants and confirms
GEA Pharma Systems’ commitment to introducing new products which are based on
sound research and development using solid process know-how and
understanding.